Universidade Federal de São Paulo
São Paulo, 04044020, Brazil
NCT Number: NCT01927874
There will be compared the postoperative analgesic effect of infiltration or spinal block for hemorrhoidectomy
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
São Paulo, 04044020, Brazil
This is a prospective, randomized study, including 40 patients between 18 and 60 years, of both genders, ASA 1 or 2.
Patients in group 1 (n = 20) will be submitted to spinal block and group 2 (n = 20) to infiltration. The spinal block will be performed with 10 mg of 0.5% bupivacaine. The infiltration will be performed with 10 ml of 0.5% bupivacaine with epinephrine on each side.
Will be evaluated: intensity of pain on a numerical scale from 0 to 10 every 15 minutes, relaxation of the sphincter muscles, intensity of pain after the operation every 30 minutes until reached the criteria for discharge, muscle strength of the lower limbs every 30 minutes, BP, HR, SO2, FR, other items that determine the conditions of discharge (urine output, nausea and vomiting), time to hospital discharge, and duration of analgesia. Adverse effects and complications will be noted.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
injection of local anesthetic, associated with general anesthesia
Other names: Local Infiltration
injection of anesthetic
Other names: subarachnoidal block
10ml 0.5% bupivacaine.
Other names: Local infiltration
Spinal punction and injection of local anesthetic
Other names: spinal anesthesia
Time frame: 24 hours
Numerical score
Time frame: 24 hours
Time frame: 24 hours
Federal University of São Paulo
Other
Comparative Study of the Analgesic Effect of Subarachnoid or Infiltration for Hemorrhoidectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00890721
Agnosia, Cardiovascular Diseases
Gdansk, Poland
View Trial DetailsNCT07159334
Cardiovascular Diseases, Digestive System Diseases
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT05089500
Cardiovascular Diseases, Digestive System Diseases
Wuhan, Hubei, China
View Trial DetailsNCT07199673
Cardiovascular Diseases, Digestive System Diseases
Lahore, Punjab Province, Pakistan
View Trial Details